MedTrace Logo

Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia

NCT00169039 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2015-04-07

No results posted yet for this study

Summary

This study will examine the physical response to clozapine or chlorpromazine in people with schizophrenia that has not improved with treatment.

Conditions

Interventions

DRUG

Clozapine

DRUG

Chlorpromazine

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Dartmouth-Hitchcock Medical Center

    collaborator OTHER

  • Commonwealth Research Center, Massachusetts

    collaborator OTHER

  • Novartis

    collaborator INDUSTRY

  • Harvard Medical School (HMS and HSDM)

    lead OTHER

Principal Investigators

  • Alan I Green, MD · Harvard Medical School (HMS and HSDM)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1994-12-31
Completion
2002-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00169039 on ClinicalTrials.gov